Enovis Corporation (ENOV) — Stock Score Summary

Enovis Corporation (ENOV) has a MoatMap StockRank of 59/100 based on Quality (42/100), Value (56/100), and Momentum (45/100) factor scores. The current signal is HOLD. Enovis Corporation, a US healthcare (medical technology) company, has an extremely poor 'SR: 14.8' (composite) score and a 'STRONG_SELL' signal. Its 'Q: 20' (quality) score is terrible, immediately failing the Terry Smith quality filter. There is no clear asymmetric macro tailwind to justify any consideration for a high-conviction fund.

Enovis Corporation is a global medical technology company dedicated to advancing musculoskeletal care through its diverse portfolio of orthopedic rehabilitation, surgical, and preventative solutions. Its competitive advantage stems from a broad product range spanning joint reconstruction, bracing, and surgical technologies, supported by established distribution channels and a focus on innovation. Enovis maintains a significant presence in the orthopedic market, addressing patient needs from injury prevention to recovery.

Key Financial Metrics

Price$25.57
Market Cap$1.4B
P/E (Forward)6.33
Price/Book1.00
Return on Equity-55.3%
Return on Invested Capital-34.7%
Debt/Equity95.34
Gross Margin61.0%
Operating Margin3.6%
Revenue Growth5.4%
Free Cash Flow$207M

Enovis Corporation operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Enovis Corporation’s (ENOV) StockRank?
MoatMap’s StockRank for Enovis Corporation (ENOV) is 59/100, with a Hold signal. It is a composite of Quality (42), Value (56), and Momentum (45) factor ranks across MoatMap’s 15,000+ stock universe.
Does Enovis Corporation have an economic moat?
Enovis Corporation (ENOV) has a Quality factor score of 42/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Enovis Corporation a buy, hold, or sell?
MoatMap’s current signal for Enovis Corporation (ENOV) is Hold, based on a StockRank of 59/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Enovis Corporation in?
Enovis Corporation (ENOV) operates in the Healthcare sector, specifically the Medical Devices industry (United States).